Minerva Neurosciences, Inc. (NERV) Stock Soaring in Premarket
Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company, has seen an increase of 9.20% in the premarket trading session. As a result, NERV stock is trading at $1.0 at the time of this writing. The increase has come after the company announced the results of its bioequivalence study. On Thursday, NERV stock closed the day at […]
Minerva Neurosciences, Inc. (NERV) Stock Soaring in Premarket Read More »